Skip to main content
Log in

Different effects of hypercalcemic state induced by walker tumor (HWCS 256) and 1,25 (OH)D3 intoxication on rat thyroid C cells

An ultrastructural, immunocytochemical, and biochemical study

  • Published:
Histochemistry Aims and scope Submit manuscript

Summary

Two different models of chronic C cell stimulation by the hypercalcemic state were compared with respect to their morphology, immunocytochemistry, and biochemistry. In the chronic hypercalcemic state due to the HWCS 256 strain of the Walker tumor C cells show signs of degeneration such as vacuolation, on day 7 after tumor implantation. On day 10 tumor induced hypercalcemia leads to irreversible cell damage with karyopyknosis and karyorhexis. These morphological changes are accompanied by a decline in radioimmunologically measurable calcitonin content of the thyroid and by the loss of response to acute stimulation of C cells. In contrast, in the hypercalcemic state due to 1,25(OH)2D3 intoxication we find an almost complete degranulation of C cells but no signs of degeneration or cell damage, although the thyroid calcitonin content and the calcitonin secretion capacity is greatly reduced. Tumor induced cachexia as a reason for C cell damage in tumor bearing rats could be excluded. Other possible reasons, such as acute overstimulation and tumor factors acting directly on C cells are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adachi J, Abe K, Tanaka M, Yamaguchi K, Miyakawa S, Hirakawa H, Tanaka N (1976) Plasma human calcitonin levels in normal and pathologic conditions and their responses to short calcium or tetragastrin infusion. Endocrinol Jpn 23:517–526

    Google Scholar 

  • Austin LA, Heath III H, Go VLW (1979) Regulation of calcitonin secretion in normal man by changes of serum calcium within the physiologic range. J Clin Invest 64:1721–1724

    Google Scholar 

  • Becker KL, Silva OL, Wisneski LA, Cyrus J, Snider RH, Moore CF, Higgins GA (1980) Limited calcitonin reserve in hyperparathyroidism. Am J Med Sci 280:11–15

    Google Scholar 

  • Deftos LJ, Burg AE, Habener JF, Singer FR, Potts JT Jr (1971) Immunoassay for human calcitonin. II Clinical Studies, Metabolism 20:1129–1137

    Google Scholar 

  • Deutschle I, Raue F, Ziegler R (1983) Reversible exhaustion (or down regulation?) of calcitonin secretion in rats with chronic hypercalcemia. Acta Endocrinol (Suppl 259) 102:23

    Google Scholar 

  • Ericsson M, Berg M, Ingemansson S, Jernby B, Järhalt J (1981) Basal and Pentagastrin-stimulated levels of calcitonin in thyroid and peripheral veins during normocalcemic anc chronic hypercalcemia in humans. Ann Surg 194:129–133

    Google Scholar 

  • Heynen G, Franchimont P (1974) Human calcitonin radioimmunoassay in normal and pathological conditions. Eur J Clin Invest 4:213–222

    Google Scholar 

  • Lambert PW, Heath III H, Sizemore GW (1979) Pre- and postoperative studies of plasmacalcitonin in primary hyperparathyroidism. J Clin Invest 63:602–608

    Google Scholar 

  • Lettré H (1953) Das Yoshida-Sarkom der Ratte. Z Krebsforsch 59:287–297

    Google Scholar 

  • Lietz MH (1970) Zur Ultrastruktur der C-Zellen in der Rattenschilddrüse bei gestörtem Calciumstoffwechsel. Virchows Arch A: Pathol Anat 350:136–149

    Google Scholar 

  • Livolsie AV, Feind CR, Logerfo P, Tashjian AH (1973) Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyreoidism. ICE & M 37:550–559

    Google Scholar 

  • Minne H, Ziegler R, Schmitt W, Hilgard P (1971) Die hyperkalzämische Aktivität des Walker Karzinosarkoms 256 bei der Ratte. Schweiz Med Wochenschr 101:481–483

    Google Scholar 

  • Minne H, Raue F, Bellwinkel S, Ziegler R (1975) The hypercalcemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinol 78:613–624

    Google Scholar 

  • Minuth M, Hackenthal E, Paulsen K, Rix E, Taugner R (1981) Renin immunocytochemistry of differentiating juxtaglomerular apparatus. Anat Embryol 162:173–181

    Google Scholar 

  • Parthemore JG, Deftos LJ (1979) Calcitonin secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 49:223–226

    Google Scholar 

  • Raue F, Hoitz A, Gottswinter J, Ziegler R (1980) Radioimmunoassay of rat calcitonin, method and application. Acta Endocrinol (Suppl) 234:128–129

    Google Scholar 

  • Silva OL, Snider RH, Becker KL (1974) Radioimmunoassay of calcitonin in human plasma. Clin Chem 20:337–339

    Google Scholar 

  • Simpson EL, Mundy GR, D'Sanza SM, Ibbotson KJ, Bockmann R, Jacobs JW (1983) Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia. N Engl J Med 309:325–330

    Google Scholar 

  • Sternberger LA (1979) Immunocytochemistry. 2nd ed. John Wiley & Sons, New York

    Google Scholar 

  • Tharaud D, Rouais F, Cressent M, Moukthar MS, Milhaud G, Blanquet P (1977) Intracellular localization of calcitonin in the C cells of the rat. Sep Experientia 33:1085–1086

    Google Scholar 

  • Zabel M (1976) The response of thyroid C-cell system in rat to long-term hypercalcemia. Endocrinology 67:315–321

    Google Scholar 

  • Zabel M (1982) Ultrastructural immunocytochemical localization of calcitonin in the C-cells of the rat thyroid. Histochemistry 75:419–424

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rix, E., Raue, F., Deutschle, I. et al. Different effects of hypercalcemic state induced by walker tumor (HWCS 256) and 1,25 (OH)D3 intoxication on rat thyroid C cells. Histochemistry 80, 503–508 (1984). https://doi.org/10.1007/BF00495442

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00495442

Keywords

Navigation